Navketan Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 28-12-2024
- Paid Up Capital ₹ 2.93 Cr
as on 28-12-2024
- Company Age 31 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.32 Cr
as on 28-12-2024
- Satisfied Charges ₹ 15.60 Cr
as on 28-12-2024
- Revenue 10.14%
(FY 2021)
- Profit 179.44%
(FY 2021)
- Ebitda 16.96%
(FY 2021)
- Net Worth 8.79%
(FY 2021)
- Total Assets -5.87%
(FY 2021)
About Navketan Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.93 Cr.
The company currently has active open charges totaling ₹6.32 Cr. The company has closed loans amounting to ₹15.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anjali Karad and Harshwardan Karad serve as directors at the Company.
- CIN/LLPIN
U24230MH1993PTC071984
- Company No.
071984
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Navketan Pharma Pvt Ltd offer?
Navketan Pharma Pvt Ltd offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream.
Who are the key members and board of directors at Navketan Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali Karad  | Director | 29-Dec-2017 | Current |
| Harshwardan Karad | Director | 16-May-2023 | Current |
Financial Performance of Navketan Pharma.
Navketan Pharma Pvt Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 10.14% increase. The company also saw a substantial improvement in profitability, with a 179.44% increase in profit. The company's net worth moved up by a moderate rise of 8.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Navketan Pharma?
In 2021, Navketan Pharma had a promoter holding of 39.62% and a public holding of 60.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Navketan Research And Laboratories Private LimitedActive 23 years 7 monthsAnjali Karad and Harshwardan Karad are mutual person
- Blackman Millennium Breweries Private LimitedActive 1 year 9 months
Harshwardan Karad is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 May 2014 | ₹5.95 Cr | Open |
Maharashtra State Financial Corporation Creation Date: 30 Jan 1995 | ₹3.65 M | Open |
Deogiri Nagari Sahakari Bank Limited Creation Date: 30 Mar 2008 | ₹1.65 Cr | Satisfied |
How Many Employees Work at Navketan Pharma?
Navketan Pharma has a workforce of 52 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Navketan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navketan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
